Position in OPK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$136,647
+$109,891 QoQ
Shares Held
91,099
+288.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 222 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 1%
Shared 7%
None 92%
Common Shares in OPK Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $443,202,768 across 29 Diagnostics & Research names. OPK ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
591,658 | $112,699,014 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
199,575 | $100,058,919 | |
| 3 | NTRA |
Natera, Inc.
|
104,096 | $28,256,858 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
52,906 | $28,018,487 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
141,227 | $27,287,880 | |
| 6 | ILMN |
Illumina, Inc.
|
154,690 | $27,199,141 | |
| 7 | LH |
Labcorp Holdings Inc.
|
84,201 | $23,576,280 | |
| 8 | A |
Agilent Technologies, Inc.
|
163,679 | $21,741,480 |
All Filings in OPK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,647 | 91,099 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $26,756 | 23,471 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,900 | 17,382 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $53,577 | 34,566 | Shares | Other | 2025-10-22 | |
| 2025-03-31 | $35,736 | 21,528 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||